article thumbnail

Benefits of blockchain in limiting counterfeit drug distribution

European Pharmaceutical Review

While the complexity of distribution networks makes counterfeit detection difficult, the research highlighted a framework for using smart contracts and distributed ledgers to tackle this problem in the drug supply chain. In conclusion, Kordestani et al. In conclusion, Kordestani et al.

article thumbnail

Hospira recalls lot of Propofol Injectable Emulsion

European Pharmaceutical Review

The affected product was distributed nationwide to wholesalers, hospitals and Department of Defense in the US between 10 June 2020 and 26 June 2020. Wholesalers or hospitals with an existing inventory of the lot should stop use and distribution and quarantine immediately. The full details are listed below: Products. Lot Number.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine

Pharmaceutical Technology

The authorisation allows the distribution of the vaccine in Scotland, Wales and England. The vaccine was also found to have a standard safety and reactogenicity profile when administered as a primary two-dose vaccination.

Medicine 119
article thumbnail

Inlet air conveyor optimisation in a continuous tablet coater

European Pharmaceutical Review

The uniformity of the film layer is of utmost importance: it directly relates to the safety and efficacy 1 of the pharmaceutical tablets. As a tablet moves through the spray zone, it receives a partial coating with a local distribution and amount depending on the conditions on the tablet’s journey through the spray zone.

article thumbnail

Drug price negotiations on the horizon

World of DTC Marketing

About 40 percent of drugs fail in preliminary Phase I studies, which assess a drug’s safety in humans and typically cost just $25 million a drug. After all, 90 percent of all drugs that enter human testing fail. But most of these failures occur early and at relatively low costs.

article thumbnail

UK recall of Clinigen’s Mexiletine hydrochloride hard capsules

European Pharmaceutical Review

Clinigen Healthcare is recalling three batches of Mexiletine hydrochloride hard capsules, indicated for the treatment of documented arrhythmias, due to a potential risk of under- or overdose, which could have consequences for the safety of patients. First distributed. First distributed. First distributed. 84 capsules.

article thumbnail

Ensuring sterility of a novel anti-VEGF bispecific antibody

European Pharmaceutical Review

Authors of the paper stated that it provides off-label use of the anti- vascular endothelial growth factor (VEGF)/angiopoietin-2 (Ang-2) biologic , “while maintaining safety in the treatment of patients”. Research has demonstrated a cost-effective storage solution for compounded faricimab kept for a maximum of 28 days.

Safety 98